416 related articles for article (PubMed ID: 22573189)
1. Systemic-onset juvenile idiopathic arthritis: the changing life of a rare disease.
Cimaz R; Von Scheven A; Hofer M
Swiss Med Wkly; 2012; 142():w13582. PubMed ID: 22573189
[TBL] [Abstract][Full Text] [Related]
2. Juvenile Idiopathic Arthritis.
Barut K; Adrovic A; Şahin S; Kasapçopur Ö
Balkan Med J; 2017 Apr; 34(2):90-101. PubMed ID: 28418334
[TBL] [Abstract][Full Text] [Related]
3. Systemic onset juvenile idiopathic arthritis: a single center experience.
Sağ E; Uzunoğlu B; Bal F; Sönmez HE; Demir S; Bilginer Y; Özen S
Turk J Pediatr; 2019; 61(6):852-858. PubMed ID: 32134578
[TBL] [Abstract][Full Text] [Related]
4. Systemic-onset juvenile idiopathic arthritis.
Cimaz R
Autoimmun Rev; 2016 Sep; 15(9):931-4. PubMed ID: 27392503
[TBL] [Abstract][Full Text] [Related]
5. Pilot study comparing the Childhood Arthritis & Rheumatology Research Alliance (CARRA) systemic Juvenile Idiopathic Arthritis Consensus Treatment Plans.
Kimura Y; Grevich S; Beukelman T; Morgan E; Nigrovic PA; Mieszkalski K; Graham TB; Ibarra M; Ilowite N; Klein-Gitelman M; Onel K; Prahalad S; Punaro M; Ringold S; Toib D; Van Mater H; Weiss JE; Weiss PF; Schanberg LE;
Pediatr Rheumatol Online J; 2017 Apr; 15(1):23. PubMed ID: 28399931
[TBL] [Abstract][Full Text] [Related]
6. Juvenile idiopathic arthritis presenting with prolonged fever.
Yeh TL; Huang FY; Shyur SD; Chen TL; Lee CS; Huang DT
J Microbiol Immunol Infect; 2010 Jun; 43(3):169-74. PubMed ID: 21291842
[TBL] [Abstract][Full Text] [Related]
7. Impact of biologics on disease course in systemic onset juvenile idiopathic arthritis.
Baris HE; Anderson E; Sozeri B; Dedeoglu F
Clin Rheumatol; 2018 Dec; 37(12):3263-3273. PubMed ID: 30238379
[TBL] [Abstract][Full Text] [Related]
8. Experience with etanercept, tocilizumab and interleukin-1 inhibitors in systemic onset juvenile idiopathic arthritis patients from the BIKER registry.
Horneff G; Schulz AC; Klotsche J; Hospach A; Minden K; Foeldvari I; Trauzeddel R; Ganser G; Weller-Heinemann F; Haas JP
Arthritis Res Ther; 2017 Nov; 19(1):256. PubMed ID: 29166924
[TBL] [Abstract][Full Text] [Related]
9. Macrophage activation syndrome in an inadequately treated patient with systemic onset juvenile idiopathic arthritis.
Juneja M; Jain R; Mishra D
Kathmandu Univ Med J (KUMJ); 2009; 7(28):411-3. PubMed ID: 20502084
[TBL] [Abstract][Full Text] [Related]
10. Juvenile idiopathic arthritis with peripheral gangrene.
Ghosh JB; Gupta D; Chattopadhyay N
Indian J Pediatr; 2006 Aug; 73(8):739-41. PubMed ID: 16936372
[TBL] [Abstract][Full Text] [Related]
11. Juvenile idiopathic arthritis: therapies in the 21st century.
Haines KA
Bull NYU Hosp Jt Dis; 2007; 65(3):205-11. PubMed ID: 17922671
[TBL] [Abstract][Full Text] [Related]
12. IL-6 blockers in systemic onset juvenile idiopathic arthritis.
Barone P; Pignataro R; Garozzo MT; Leonardi S
Immunotherapy; 2016; 8(1):79-87. PubMed ID: 26642378
[TBL] [Abstract][Full Text] [Related]
13. Successful treatment with tocilizumab every 4 weeks of a low disease activity group who achieve a drug-free remission in patients with systemic-onset juvenile idiopathic arthritis.
Kostik MM; Dubko MF; Masalova VV; Snegireva LS; Kornishina TL; Chikova IA; Isupova EA; Kuchinskaya EM; Glebova NI; Buchinskaya NV; Kalashnikova OV; Chasnyk VG
Pediatr Rheumatol Online J; 2015; 13():4. PubMed ID: 25685108
[TBL] [Abstract][Full Text] [Related]
14. Evidence for Tocilizumab as a Treatment Option in Refractory Uveitis Associated with Juvenile Idiopathic Arthritis.
Tappeiner C; Mesquida M; Adán A; Anton J; Ramanan AV; Carreno E; Mackensen F; Kotaniemi K; de Boer JH; Bou R; de Vicuña CG; Heiligenhaus A
J Rheumatol; 2016 Dec; 43(12):2183-2188. PubMed ID: 27633821
[TBL] [Abstract][Full Text] [Related]
15. The outcomes of juvenile idiopathic arthritis in children managed with contemporary treatments: results from the ReACCh-Out cohort.
Guzman J; Oen K; Tucker LB; Huber AM; Shiff N; Boire G; Scuccimarri R; Berard R; Tse SM; Morishita K; Stringer E; Johnson N; Levy DM; Duffy KW; Cabral DA; Rosenberg AM; Larché M; Dancey P; Petty RE; Laxer RM; Silverman E; Miettunen P; Chetaille AL; Haddad E; Houghton K; Spiegel L; Turvey SE; Schmeling H; Lang B; Ellsworth J; Ramsey S; Bruns A; Campillo S; Benseler S; Chédeville G; Schneider R; Yeung R; Duffy CM;
Ann Rheum Dis; 2015 Oct; 74(10):1854-60. PubMed ID: 24842571
[TBL] [Abstract][Full Text] [Related]
16. [Biological treatment in severe Still's disease--a case report].
Suszek D; Koszarny A; Jeleniewicz R; Majdan M; Bończak A; Czukiewska A; Koszła B; Kurlej S; Markowicz J; Szymczyk A
Wiad Lek; 2015; 68(1):104-7. PubMed ID: 26094343
[TBL] [Abstract][Full Text] [Related]
17. Systemic Juvenile Idiopathic Arthritis: Diagnosis and Management.
Kumar S
Indian J Pediatr; 2016 Apr; 83(4):322-7. PubMed ID: 26916892
[TBL] [Abstract][Full Text] [Related]
18. Initial manifestations and clinical course of systemic onset juvenile idiopathic arthritis: a ten-year retrospective study.
Tsai HY; Lee JH; Yu HH; Wang LC; Yang YH; Chiang BL
J Formos Med Assoc; 2012 Oct; 111(10):542-9. PubMed ID: 23089689
[TBL] [Abstract][Full Text] [Related]
19. Atypical clinical presentation of systemic juvenile idiopathic arthritis or Still's disease: a report of two cases.
Tiogouo E; Eloundou P; Moukodi H; Fozeu L; Wafeu GS
Pan Afr Med J; 2020; 36():12. PubMed ID: 32774589
[TBL] [Abstract][Full Text] [Related]
20. JAMA patient page. Juvenile idiopathic arthritis.
Chang HJ; Burke AE; Glass RM
JAMA; 2010 Apr; 303(13):1328. PubMed ID: 20371795
[No Abstract] [Full Text] [Related]
[Next] [New Search]